Clinical pharmacotherapy for obesity: Current drugs and those in advanced development

Current Drug Targets

Volumn 5, Issue 7, 2004, Pages 637-646

  Halford, Jason C G ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 [1 (4 CHLOROPHENYL)CYCLOBUTYL] 3 METHYL 1 METHYLAMINOBUTANE; 1 AMINO 1 [1 (4 CHLOROPHENYL)CYCLOBUTYL] 3 METHYLBUTANE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA TOCOPHEROL; AMFEPRAMONE; ANTIOBESITY AGENT; ATL 962; CENTRAL NERVOUS SYSTEM AGENTS; DEXFENFLURAMINE; DRUG METABOLITE; ENZYME INHIBITOR; FAT; FENFLURAMINE; FLUOXETINE; MAZINDOL; NON PRESCRIPTION DRUG; PHENTERMINE; PHENYLPROPANOLAMINE; PLACEBO; RETINOL; RIMONABANT; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TOPIRAMATE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN; VITAMIN D; VITAMIN K GROUP;

ABDOMINAL PAIN; AVERSIVE BEHAVIOR; CANCER INCIDENCE; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONSTIPATION; DEFECATION DISORDER; DIET THERAPY; DISEASE ASSOCIATION; DIZZINESS; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MARKETING; DRUG MECHANISM; DRUG METABOLISM; FECES INCONTINENCE; FLATULENCE; GASTROINTESTINAL SYMPTOM; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HEART ARRHYTHMIA; HEART PALPITATION; HUMAN; HYPERTENSION; INSOMNIA; NAUSEA; NEPHROLITHIASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PARESTHESIA; PRESCRIPTION; PREVALENCE; PSYCHOMOTOR DISORDER; REVIEW; RISK FACTOR; SIDE EFFECT; TACHYCARDIA; UNITED STATES; VASODILATATION; VITAMIN DEFICIENCY; WEIGHT REDUCTION; XEROSTOMIA;

ANTI-OBESITY AGENTS; APPETITE DEPRESSANTS; CYCLOBUTANES; ENERGY METABOLISM; FOOD HABITS; FRUCTOSE; HUMANS; LACTONES; OBESITY; PIPERIDINES; PYRAZOLES; RANDOMIZED CONTROLLED TRIALS;

EID: 4544237550     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389450043345191     Document Type: Review

References (112)

1. Mokdad, A., Ford, E.S., Bowman, B.A., Dietz, W.H., Vinicor, F., Bales, V.S., Marks, J.S. (2003) JAMA, 289, 76-9.
2. Mokdad, A.H., Marks, J.S., Stroup, D.F., Gerbering, J.L. (2004) JAMA, 291, 1238-45.
3. Goldstein, D.J. (1992) Int. J. Obesity, 16, 397-415.
4. Williamson, D.F., Pamuk, E., Thun, M., Flanders, D., Byers, T., Heath, C. (1995). Am. J. Epidemiology, 141, 1128-41.
5. National Heart, Lung, and Blood Institute. (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The evidence report. US Department of Health and Human Services, Washington DC, US.
6. Finer, N. (2002) Int. J. Obesity, 26 (s4), s29-33.
7. Arterburn, D.E., Crane, P.K., Veenstra, D.L. (2004) Arch. Intern. Med., 164, 994-1003.
8. Tonstad, S., Pometta, D., Erkelens, D.W., Ose, L., Moccetti, T., Schouten, J.A., Golay, A., Reitsma, J., Del Bufalo, A., Pasotti, E., van der Wal, P. (1994) Eur. J. Clin. Pharmacol., 24, 405-10.
9. Val Gaal, L.F., Broom, J.L., Enzi, G., Toplak H. (1998) Eur. J. Clin. Pharmacol., 54, 125-32.
10. McDuffie, J.R., Calis, K.A., Booth, S.L., Uwaifo, G.I., Yanovski, J.A. (2002) Pharmacotherapy, 22, 814-22.
11. Pace, D.G., Blotner, S., Guerciolini, R. (2001) J. Nutr., 131, 1694-9.
12. Ferraz, R.R.N., Tiselius, H-G., Heiberg, I.P. (2004) Kidney International, 66, 676-82.
13. Hauptman, J.B., Jeunet, F.S., Hartmann, S. (1992) Amer. J. Clin. Nutr., 55, s309-22.
14. Schwizer, A., Asal, K., Kreiss, C., Mettraus, C., Borovicka, J., Remy, B., Guzelhan, C., Hartmann, D., Fried, M. (1997) Am. J. Physiol., 273, G612-20.
15. Sternby, B., Hartmann, D., Borgström, B., Nilsson, Å. (2002) Clin. Nutr., 21, 395-402.
16. Zhi, J., Melia, A.T., Eggers, H., Joly, R., Patel, I.H. (1995) J. Clin. Pharmacol., 35, 1103-8.
17. Guerciolini, R. (1997) Int. J. Obesity., 21, s12-23.
18. Vidgreen, H.M., Ågren, J.J., Valve, R.S., Karhunen, L.J., Risanen, A.M., Uusitupa, M.I.J. (1999) Clin. Pharmacol. Ther., 66, 315-22.
19. Mittendorfer, B., Ostlund, R.E., Patterson B.W., Klein, S. (2001) Obesity Research, 9, 599-603.
20. Halpern, A., Mancini, M.C. (2003) Obesity Reviews, 4, 25-42.
21. Hildebrand, P., Petrig, C., Burckhardt, B., Ketterer, S., Lengsfeld, H., Fleury, A., Hadvary, P., Beglinger, C. (1998) Gasterenterology, 114, 123-9.
22. Matzinger, D., Degen, L., Drewe, J., Meuli, J., Duebendorfer, R., Ruckstuhl, N., D'Amato, M., Rovati, L., Beglinger, C. (2000) Gut, 46, 600-93.
23. O'Donovan, D., Feinle-Bisset, C., Wishart, J., Horowitz, M. (2003) Br. J. Nutr., 90, 849-52.
24. Goedecke, J.H., Barsdof, M., Beglinger, C., Levitt, N.S., Lambert, E.V. (2003) Int. J. Obesity, 27, 1479-85.
25. Demarchi, B., Vis, R., Deprez, P., Jannssens, J., Tack, J. (2004) Aliment. Pharmacol. Ther., 19, 1261-8.
26. Mathus-Vliegen, E.M.H., Van Ierland-Van Leeuwen, M.L., Terpstra, A. (2004) Aliment. Pharmacol. Ther., 19, 601-11
27. Zhi, J., Mulligan, T.E., Hauptman, J.B. (1999) J. Clin. Pharmacol., 39, 41-6.
28. Ackroff, K., Sclafani, A. (1996) Am. J. Physiol., 271, R48-54.
29. Ullrich, A., Erdmann, J., Margraf, J., Schusdziarra, A. (2003) Aliment. Pharmacol. Ther., 17, 1007-13.
30. Ballinger, A., Peikin, S.R. (2002) Eur. J. Pharmacol., 440, 109-17.
31. Haddock, C.K., Poston, W.S.C., Dill, P.L., Froreyt J. P., Ericsson, M. (2002) Int. J. Obesity, 26, 262-273.
32. Padwal, R., Li, S.K., Lau, D.C.W. (2003) Int. J. Obesity, 27, 1437-46
33. O'Meara, S., Riemsma, R., Shirran, L., Mather, L., Ter Riet, G. (2004) Obesity Reviews, 5, 51-68.
34. Drent, M.L., Larrson, I., William-Olsson, T. (1995) Int. J. Obesity, 19, 221-6.
35. Drent, M.L., Popp-Snijders, C., Adàr, H.J., Jansen, J.B.M.J., Van der Veen, E.A. (1995) Obesity Research, 3, 573-81.
36. Sjöström, L., Rissanen, A., Andersen, T., Boldrin, M., Golay, A., Kopperchaar, H.P.F., Krempf, M. (1998) Lancet, 352, 167-172
37. Hollander, P.A., Kaplan, R.A., Elbein, S.C., Comstrock, J., Hirsh, I.B., Lucas, C.P., Kelley, D., Lodewick, P.A., McGill, J., Canovatchel, A., Taylor, T., Chung, J., Weiss, S.R., Hauptman, J., Crockett, S.E. (1998) Diabetes Care, 21, 1288-94.
38. Hill, J.O., Hauptman, J., Anderson, J.W., Fukioka, K., O'Neil, P.M., Smith, S.K., Zavoral, J.H., Aronne, L. J. (1999) Am. J. Clin. Nutr., 69, 1108-16.
39. Davidson, W.H., Hauptman, J., Di Girolamo, M., Foryet, J.P., Halstead, C.H., Hebei, D., Heimburger, D.G., Lucas, C.P., Robbins, S.C., Chung J., Heymsfeidl, S.B. (1999) JAMA, 281, 235-42.
40. Finer, N., James, W.P.T., Kopelman, P.G., Lean, M.E.J., Williams, G. (2000) Int. J. Obesity, 24, 306-13.
41. Rössner, S., Sjöström, L., Noak, R., Meimnders, A.E., Noseda, G. (2000) Obesity Research, 8, 49-61.
42. Karkunen, L., Franssila-Kallunki, A., Rissanen, P., Valuve, R., Kolechmainene, M., Rissanen, A., Uusitupa, M. (2000) Int. J. Obesity, 24, 1567-72.
43. Bakris, G., Calhoun, D., Egan,B., Hellmann, C, Dolker, M., Kingmam I. (2002) J. Hypertension, 20, 2257-67.
44. Zavoral, J.H. (1998) J. Hypertension, 16, 2013-17.
45. Heymsfield, S.B., Segal, K.R., Hauptman, J., Lucas, C.P., Boldrin, M.N., Rissanen, A., Wilding, J.P.H., Sjöström, L. (2000) Arch. Intern. Med., 160, 1321-26.
46. Hauptman J., Lucas, C., Boldrin, M.B., Collins, H., Segal, K.R. (2000) Arch. Fam. Med., 9, 16-167.
47. Lindgärde F. (2000) J. Intern. Med., 248, 245-54.
48. Reaven, G., Segal, K., Hauptmanm J., Boldrin, M., Lucas, C. (2001) Am. J. Cardiology, 87, 827-31.
49. Tan, K.C.B., Tso, A.W.K., Tam. S.C.F., Pang, R.W.C., Lam, K.S.L. (2002) Diabetic Medicine, 19, 944-8.
50. Kelley, D.E., Hill, J., Bray, G.A., Miles, J., Pi-Sunyer, F.X., Hollander, P., Klein, S. (2002) Diabetes Care, 25, 1033-41.
51. Miles, J.M., Doyle, M., Leiter, L., Foreyt, J., Hollander, P., Aronne, L., Wadden, T., Klein, S., Anderson, J.W. (2002) Diabetes Care, 22, 1123-8.
52. Lucas, C.P., Boldrin, M.N., Reaven, G.M. (2003) Am. J. Cardiol., 91, 961-4.
53. Torgerson, J.S., Hauptman, J., Boldrin, M.N., Sjöström, L. (2004) Diabetes Care, 27, 155-61.
54. Kopelman, P., Bryson, A.M., Palmer, R.M.J. (2004) Int. J. Obeisty, 28 (Suppl. 1), s28.
55. Heal, D.J., Aspely, A., Prow, MR., Jackson, H.C., Martin, K.F., Cheetham, S.C. (1998) Int. J. Obesity, 22 (Suppl. 1), s18-s28.
56. Cole, J,O., Levin, A., Beake, B., Kaiser, P.E., Scheinbaum, M.L. (1998) J. Clin. Psychopharmacol., 18, 231-36.
57. Schuh, L.M., Schuster, C.R., Hopper, J.A., Mendel, C.M. (2000) Psychopharmacology, 147, 339-46.
58. Halford, J.C.G., Wanninayake, S.C.D., Blundell, J.E. (1998) Pharmacol. Biochem. and Behav., 61, 159-168.
59. Jackson, H.C., Bearham, M.C., Mazurkiewicz, S.E., Needham, A.M., Heal, D.J. (1997) Br. J. Pharmacol., 121, 1613-8.
60. Halford, J.C.G., Dovey, T.M., Cooper, G.D. (2004) Current Drug Targets, 5, 221-240.
61. Hansen, D.L., Toubro, S., Stock, M.J., Macdonald, I.A., Astrup, A. (1998) Am. J. Clin. Nuir., 68, 1180-6.
62. Chapelot, D., Marmonier, C., Thomas, F., Hanotin, C. (2000) Physiol. Behav., 68, 299-308.
63. Rolls, B.J., Shide, D.J., Thorwart, M.L., Ulbrecht., J.S. (1998) Obesity Research, 6, 1-11.
64. Hansen, D.L., Toubro, S., Stock, M.J., Macdonald, I.A., Astrup, A. (1999) Int. J. Obesity, 23, 10160-24.
65. Barkeling B., Elfhag, K., Rooth, P., Rössner, S. (2003) Int. J. Obesity, 27, 693-700.
66. Stock, M.J. (1997) Int. J. Obesity, 21(Suppl. 1), s25-s29.
67. Day, D., Baily, C.J. (1998) Int. J. Obesity, 22, 619-23.
68. Hanotin, C., Thomas, F., Jones, S.P., Leutenegger, E., Drourin P. (1998) Obesity Research, 6, 285-91.
69. Hanotin, C., Thomas, F., Jones, S.P., Leutenegger, E., Drourin P. (1998) Int. J. Obesity, 22, 32-8.
70. Seagle, H.M., Bessesen, D.H., Hill, J.O. (1998) Obesity Research, 6, 115-121.
71. Walsh, K.M., Leen, E., Lean, M.E.J. (1999) Int. J. Obesity, 23, 1009-15.
72. Weintraub, M., Rubio, A., Golik, A., Byrne, L., Scheinbaum, M.L. (1991) Clin. Pharmacol. Ther., 50, 330-7.
73. Finer, N., Bloom, S.R., Frost, G.S., Banks, L.M., Griffiths, J. (2000) Diabetes, Obesity and Metabolism, 2, 105-12.
74. Ryan, D.H., Faiser, P., Bray, G.A. (1995) Obesity Research, 3(s4), 553s-9s.
75. Bray, G.A., Ryan, D.H., Gordon, D., Heidingsfelder, S., Cerise F., Wilson, J. (1996) Obes. Res., 4, 263-70
76. Bray, G.A., Blackburn, G.L., Ferguson, J.M., Greenway, F.L., Jain, A.K., Mendel, C.M., Mendels, J., Ryan, D.H., Schartz, S.L., Scheinbaum, M.L., Seaton. T.B. (1999) Obesity Research, 7, 189-98.
77. Cuellar, GF.E.M., Ruiz, AQ.M., Monsalva, M.C.R., Berber. A. (2000) Obesity Research, 8, 71-82.
78. Fanghänel, G., Cortinas, L., Sánchez-Reyes, L., Berber, A. (2000) Int. J. Obesity, 24, 144-150.
79. Fujioka, K., Seaton, T.B., Rowe, E., Jelinek, C.A., Raskin, P., Lebovitz, H.E., Weinstein, S.P. (2000) Diabetes, Obesity and Metabolism, 2, 175-87.
80. Dujovne, C.A., Zavoral, J.H., Rowe, A., Mendel, C.M. (2001) Am. Heart J., 142, 489-97.
81. Gokcel, A., Tanaci, N., Karakose, H., Tutuncu, N.B., Ertorer, E.M., Guvener, N. (2001) Diabetes Care, 24, 1957-60.
82. Zannad, F., Gille, B., Grentzinger, A., Bruntz, J-F., Hammadi, M., Boivin, J-M., Hanotin, C., Igau, B., Drouin, P. (2002) Am. Heart. J., 144, 508-15.
83. Apfeklbaum, M., Vague, P., Zieler, O., Hanotin, C., Thomas F., Leutenegger, E. (1999) Am. J. Med., 106, 179-184
84. James, W.P.T., Astrup, A., Finer, N., Hiltes, J., Kopleman, P., Rössner, S., Saris, W.H.M., Van Gaal, L.F. (2000) Lancet, 356, 2119-25.
85. Hansen, D.L., Astrup, A., Toubro, S., Finer, N., Kopelman, P., Hilsted, J., Rössner, S., Saris, W.H.M., Van Gaal, L.F., James, W.P.T., Goulder, M. (2001) Int. J. Obesity, 25, 496-501.
86. McMohan, F.G., Fujioja, K., Singh, B.N., Mendel, C.M., Rowe, R., Rolston, K., Johnson F., Morradian, A.D. (2000) Arch. Intern. Med., 160, 2185-91.
87. Smith, I.G., Goulder, M.A. On behalf of the Members of the Sibutramine Clinical Study 1047 Team. (2001) J. Fam. Pract. 50, 505-12.
88. Wirth, A., Krause, J. (2001) JAMA, 286, 1331-9.
89. McNulty S.J., Ur, E., Williams, G. (2003) Diabetes Care, 26, 125-33.
90. Sharma, A.M. (2001) Int. J. Obesity, 25(s4), s20-s23.
91. Kim, S.H., Lee, Y.M., Jee, H.J., Nam, C.M. (2003) Obesity Research, 11, 1116-23.
92. Van Gaal, L.F., Peiffer, F.W. (2001) Int. J. Obesity, 25(s4), s24-s28.
93. Redmon, J.B., Kwong, C.A., Raatz, S.K., Fan, Q., Beck, K.P., Thomas, W., Swanson, J.E., Bantle, J.P. (2003) Diabetes Care, 26, 2505-11.
94. Gokcel, A., Gumurdulu, Y., Karakose, H., Ertorer, A.M., Tanaci, N., Bascil, N., Tutuncu, N.B., Guvener, N. (2002) Diabetes, Obesity and Metabolism, 4, 49-55.
95. Aydin, N., Topsever, P., Kaya, A., Karasako M., Duman, C., Daǧar, A. (2004) J. Exp. Med., 202, 173-80.
96. Wadden T.A., Berkowitz, R.I., Womble, L.G., Sarwer, D.B., Arnold, M.E., Steinburg, C.M. (2000) Obesity Research, 8, 431-7.
97. Colombo, G., Agabio, R., Diaz, G., Lobina, C., Rali, R., Gessa, G.L. (1998) Life Sci., 63, 113-7.
98. Trillou, C.T., Arone., A., Delgorge, C., Gonalon, A., Keane, P., Maffrand, J-P., Soubrié, P. (2003) Am. J. Physiol., 284, R345-R353
99. Kirkham T.C. (2003) Am. J. Physiol., 284, R343-R344
100. Vickers, S.P., Webster, L.J., Wyatt, A., Dourish, C.T., Kennett, G.A. (2003) Psychopharmacol., 167, 103-11.
101. Heshmati, H.M., Caplain, H., Bellisle, F., Mossé, M., Fauveau, C. (2001) Obesity Research, 9(S), s71 O69
102. Jensen, M., Abu-Lebdeh, H., Geohas, J., Brazg, R., Block, M., Noveck, R., Free, R. (2004) Int. J. Obesity, 28 (Suppl. 1), s27.
103. Drent, M. L., Van der Veen, E.A. (1993) Ini. J. Obesity, 17, 241-44.
104. Poston, W.S.C., Reeves, R.S., Haddock, C.K., Stormer, S., Balasubramanyam, A., Satterwhite, O., Taylor, J.E., Foreyt, J.P. (2003) Int. J. Obesity, 27, 1486-93.
105. Ben-Mechachem, E., Axelsen, A., Johanson, E.H., Stagge, A., Smith, U. (2003) Obesity Research, 11, 556-62.
106. Gadde, K.M., Francisey, D.M., Wagner, H.R., Krishnan, K.R.R. (2003) JAMA, 289, 1820-5.
107. Appolinario, J.C., Bueno. J.R., Coutinho, W. (2004) CNS Drugs, 18, 629-651.
108. Richard, D., Ferlan, J., Lalonde, J., Samson, P., Deshaies, Y. (2000) Nutrition, 16, 961-66.
109. Richard, D., Picard, F., Lemieux, C., Lalonde, J., Samson, P., Deshales, Y. (2002) Int. J. Obesity, 26, 344-53.
110. Bray, G.A., Hollander, P., Klein S., Kushner, R., Levy, B., Fitchet, M., Perry, B.H. (2003) Obesity Research, 11, 722-33.
111. Wilding, J., Van Gaal, L., Rissansen, A., Vercruysse, F., Cooper, B.H., Fitchet, M. (2004 Int. J. Obesity, In press.
112. Stafford, R.S., Radley, D.C. (2003) Arch. Intern. Med., 163, 1046-50.